| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Departments of Therapeutic Radiology and Genetics, Yale University School of Medicine, New Haven, Connecticut 06520-8040 [M. Z., L. N., X. S. X., P. M. G.]; Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon 97201-3098 [R. M. L.]; and University of WisconsinMadison, Departments of Genetics and Medical Genetics, Madison, Wisconsin 53706 [T. A. P.]
The cytotoxicity of ionizing radiation (IR) has been associated with both the p53 pathway and with DNA mismatch repair (MMR). p53 mediates cell cycle arrest and apoptosis in response to X-ray damage, whereas the MMR complex is thought to recognize damaged bases and initiate a signal transduction pathway that can include phosphorylation of p53. To determine whether p53 and MMR mediate X-ray cytotoxicity via the same pathway, mice with targeted disruptions in either the p53 gene or the MutL homologue MMR gene Pms2 were interbred and primary fibroblasts were established from the progeny with genotypes of either wild type, p53 null, Pms2 null, or double null. Cells with either p53 or Pms2 separately disrupted showed reduced levels of apoptosis after IR in comparison with wild type, but the double null cells showed even lower levels, consistent with nonoverlapping roles for p53 and PMS2 in the X-ray response. In transformed cell lines established from the primary cells at early passage, similar differences in the apoptotic response to IR were seen, and clonogenic survival assays following low dose rate IR further showed that nullizygosity for Pms2 confers increased survival on cells in both wild-type and p53 null backgrounds. These results indicate that both p53 and MMR contribute to X-ray-induced apoptosis and that the role of MMR in the cytotoxicity of IR does not depend on p53.
This article has been cited by other articles:
![]() |
C. E. Schaller, C. L. Wang, G. Beck-Engeser, L. Goss, H. S. Scott, M. S. Anderson, and M. Wabl Expression of Aire and the Early Wave of Apoptosis in Spermatogenesis J. Immunol., February 1, 2008; 180(3): 1338 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Seo, T. Yan, J. E. Schupp, V. Colussi, K. L. Taylor, and T. J. Kinsella Differential Radiosensitization in DNA Mismatch Repair-Proficient and -Deficient Human Colon Cancer Xenografts with 5-Iodo-2-pyrimidinone-2'-deoxyribose Clin. Cancer Res., November 15, 2004; 10(22): 7520 - 7528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Young, K. J. Thulien, M. R. Campbell, V. A. Tron, and S. E. Andrew DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study Carcinogenesis, October 1, 2004; 25(10): 1821 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Papouli, P. Cejka, and J. Jiricny Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells Cancer Res., May 15, 2004; 64(10): 3391 - 3394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cortellino, D. Turner, V. Masciullo, F. Schepis, D. Albino, R. Daniel, A. M. Skalka, N. J. Meropol, C. Alberti, L. Larue, et al. From The Cover: The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity PNAS, December 9, 2003; 100(25): 15071 - 15076. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. N. Dobrovolsky, P. B. McKinzie, J. G. Shaddock, R. A. Mittelstaedt, R. H. Heflich, and B. L. Parsons Pms2 deficiency results in increased mutation in the Hprt gene but not the Tk gene of Tk+/- transgenic mice Mutagenesis, July 1, 2003; 18(4): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimodaira, A. Yoshioka-Yamashita, R. D. Kolodner, and J. Y. J. Wang Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin PNAS, March 4, 2003; 100(5): 2420 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yan, J. E. Schupp, H.-s. Hwang, M. W. Wagner, S. E. Berry, S. Strickfaden, M. L. Veigl, W. D. Sedwick, D. A. Boothman, and T. J. Kinsella Loss of DNA Mismatch Repair Imparts Defective cdc2 Signaling and G2 Arrest Responses without Altering Survival after Ionizing Radiation Cancer Res., November 1, 2001; 61(22): 8290 - 8297. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. S. Xu, L. Narayanan, B. Dunklee, R. M. Liskay, and P. M. Glazer Hypermutability to Ionizing Radiation in Mismatch Repair-deficient, Pms2 Knockout Mice Cancer Res., May 1, 2001; 61(9): 3775 - 3780. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |